Trametinib response in heavily pretreated high-grade ovarian cancer: one step towards precision medicine
Gynecologic Oncology Reports（2020）
摘要
•New therapies are needed for advanced or recurrent high-grade ovarian cancer.•Genetic and molecular tests may help in directing therapeutic options according to sensitivity profiles.•Trametinib showed promising response in our patient affected by heavily pretreated high-grade ovarian cancer.
更多查看译文
关键词
Ovarian neoplasm,Ovarian epithelial cancer,Genetic testing,Precision medicine,Target therapy,Trametinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要